CVS Health Corp.
CVS · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 5, 2026 | — | 100.07B | — | 1.87 | — |
| 2026 Q1 | May 6, 2026 | 100.43B | 94.99B | 2.30 | 2.21 | +7.65% |
| 2025 Q4 | February 10, 2026 | 105.69B | 103.70B | 1.09 | 0.99 | -0.09% |
| 2025 Q3 | October 29, 2025 | 102.87B | 98.81B | 1.60 | 1.36 | -1.95% |
| 2025 Q2 | July 31, 2025 | 98.92B | 94.53B | 1.81 | 1.47 | -0.32% |
| 2025 Q1 | May 1, 2025 | 94.59B | 93.68B | 2.25 | 1.71 | +4.11% |
| 2024 Q4 | February 12, 2025 | 97.71B | 97.09B | 1.19 | 0.89 | +14.95% |
| 2024 Q3 | November 6, 2024 | 95.43B | 92.75B | 1.09 | 1.27 | +11.33% |
| 2024 Q2 | August 7, 2024 | 91.23B | 91.41B | 1.83 | 1.74 | -3.21% |
| 2024 Q1 | May 1, 2024 | 88.44B | 89.33B | 1.31 | 1.69 | -16.84% |
| 2023 Q4 | February 7, 2024 | 93.81B | 90.36B | 2.12 | 2.01 | +3.10% |
| 2023 Q3 | November 1, 2023 | 89.76B | 88.25B | 2.21 | 2.13 | -0.41% |
| 2023 Q2 | August 2, 2023 | 88.92B | 86.53B | 2.21 | 2.13 | +3.33% |
| 2023 Q1 | May 3, 2023 | 85.28B | 80.81B | 2.20 | 2.07 | -3.68% |
| 2022 Q4 | February 8, 2023 | 83.85B | 76.43B | 1.99 | 1.92 | +3.47% |
| 2022 Q3 | November 2, 2022 | 81.16B | 76.74B | 2.09 | 1.99 | +2.30% |